Skip to main content
Optibrium appoints Dr Hamed Tabatabaei Ghomi as Head of Research
Collaboration aims to Integrate AI drug discovery
Optibrium appoints Ian Smith to manage expanding portfolio of products
Software helps advance predictive modelling for drug-metabolising enzymes
Optibrium expands operations in North America
Optibrium expands UK head office with new facilities on Cambridge Innovation Park
Supercharging the bioinformatics data silo
Optibrium adds augmented intelligence for compound design to its StarDrop software
Optibrium applies deep learning to predict human panel-based sensory perception of novel compounds
Optibrium and BioPharmics partnership on computational drug design

Media Partners